NEW YORK, April 3, 2025 /PRNewswire/ -- A new JMIR Formative Research study highlights the innovative patient care model pioneered by Vori Health, where musculoskeletal patients are evaluated simultaneously by both a specialty non-operative physician and physical therapist (PT) in a single telehealth visit. This first-of-its-kind nationwide "MD+PT" approach eliminates weeks of waiting between appointments while offering comprehensive medical diagnosis and treatment capabilities unavailable in physical therapy-only solutions. The study examined patient experiences with this unique integrated model, revealing significant advantages that transform the traditional musculoskeletal care journey. "Musculoskeletal care has traditionally been fragmented, with patients caught in a maze of multiple clinicians who rarely communicate directly with each other," said Dr. Mary I. O'Connor, Vori Health's Co-Founder and Chief Medical Officer

Vori Health, a NYC-based provider of a physician-led solution for musculoskeletal care, raised $53M in Series B funding.

NEW YORK, March 11, 2025 /PRNewswire/ -- Vori Health, the nation's pioneering physician-led solution for musculoskeletal care, is making waves in the healthcare industry and just announced a $53 million Series B funding round. Led by NEA and with continued support from AlleyCorp, Intermountain Health's Intermountain Ventures, Echo Health Ventures, and Max Ventures, this heavily oversubscribed round is a testament to Vori Health's rapid growth and innovative care model. In just 18 months, the company has delivered remarkable clinical outcomes and significant cost savings for patients and partners alike, while achieving an 800% revenue increase. Founded to revolutionize the U.S. musculoskeletal care system in which patients often endure fragmented treatment paths, unnecessary surgeries, and subpar outcomes at premium costs, Vori Health's comprehensive physician-led approach has achieved extraordinary milestones since its Series A funding. These transformative results include 91.6% of patients reporting clinically significant pain improvement, a remarkable 78-90% reduction in elective orthopedic surgeries, a 42% decrease in opioid utilization, and up to a 68% reduction in depression and anxiety among patients